Hemodiafiltration Combined with Resin-Mediated Absorption as a Therapy for Hyperlipidemic Acute Pancreatitis

Cell Biochemistry and Biophysics - Tập 69 - Trang 699-702 - 2014
Mao-qin Li1, Zai-xiang Shi1, Ji-yuan Xu1, Bo Lu1, Jia-qiong Li1, Yan-jun Xu1, Xiao-meng Wang1, Song-mei Li1, Xun Mo1
1Department of Intensive Care, Xuzhou Central Hospital, Xuzhou Hospital Affiliated to School of Medicine, Southeast University, Jiangsu, China

Tóm tắt

The aim of this study is to investigate whether hemodiafiltration combined with resin-mediated absorption is a better therapy for hyperlipidemic acute pancreatitis. Patients (n = 67) with acute pancreatitis treated in ICU from January 2009 to December 2012 were included in this study. Seven of these 67 cases were diagnosed hyperlipidemic acute pancreatitis (HLAP). All the 7 HLAP patients went through fast, gastrointestinal decompression, anti-shock treatment, inhibition of pancreatic secretion, antiseptic treatments, and hemoperfusion (HP) combined with continuous veno venous hemodiafiltration (CVVHDF). After one round of treatment by resin adsorption, there was a significant decrease in serum triglycerides (TG) (29.78 %) and total cholesterol (TC) (24.02 %) levels (p < 0.01). TG and TC levels dropped by 49.02 and 37.66 %, respectively, after 1-day treatment of HP + CVVHDF; by 62.81 and 47.37 % on day 2 post-treatment; and by 69.57 and 49.47 % on day 3 post-treatment. All the 7 patients survived. The average time spent in the ICU was 7 ± 3.8 days, and the average duration of hospitalization was 19 ± 15.1 days. Our results show that hemoperfusion combined with hemodiafiltration is an efficient treatment as this approach can reduce plasma lipid levels effectively and reduce the risk of acute pancreatitis due to hyperlipidemia.

Tài liệu tham khảo

Yuan, H., Sun, J., Li, F., et al. (2006). The clinical characteristics of hyperlipidemic pancreatitis. Journal of Capital University of Medical Sciences, 27, 365. Li, B., Cui, N., Zhao, E., et al. (2011). The clinical analysis of hyperlipidemic pancreatitis. Chinese Journal of Surgery of Integrated Traditional and Western Medicine, 17, 126–129. Navarro, S., Cubiella, J., Feu, F., et al. (2004). Hypertriglyceridemic acute pancreatitis. Is its clinical course different from lithiasis acute pancreatitis. Medicina Clínica (Barcelona), 123, 567–570. Yadav, D., & Pitchumoni, C. S. (2003). Issues in hyperlipidemic pancreatitis. Journal of Clinical Gastroenterology, 36, 54–62. Kyriakidis, A. V., Raitsiou, B., Sakagianni, A., et al. (2006). Management of acute severe hyperlipidemic pancreatitis. Digestion, 73(4), 259–264. Iskandar, S. B., & Olive, K. E. (2004). Plasmapheresis as an adjuvant therapy for hypertriglyceridemia-induced pancreatitis. The American Journal of the Medical Sciences, 328, 290. Zhang, J., Li, K., Yan, Z., et al. (2002). A preliminary investigation of the hemoperfusion therapy for hyperlipidemia. Chinese Journal of Blood Purification, 1, 52–53. Jia, C. (2008). Clinical observation of 9 cases with severe acute hyperlipidemic pancreatitis after hemodiafiltration therapy combine with hemoperfusion therapy. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, 15, 349.